The United States government has issued a national security legal order to Anthropic to suspend access to their new Fable 5 and Mythos 5 AI Models. The order effectively compels Anthropic to cut ...

LOS ANGELES − The biggest question swirling around the star-studded "Toy Story 5" premiere on June 9 had to do with a superstar who doesn't voice a character in the wildly anticipated animated sequel ...

Opening moments of games can often feel long and slow, and may even be boring as the game must teach you how to play it first thing. They’re a necessary evil, but there's a new high bar, as the new ...

Anker’s Soundcore sub-brand spent years punching above its weight in the budget and midrange earbuds market, and Liberty 5 Pro is an ambitious new swing. Released alongside the pricier Liberty 5 Pro ...

If you haven't seen the latest Java developer productivity report from Perforce, you should check it out. Written by Perforce CTO Rod Cope and developer tools exec Jeff Michael, the "2025 Java ...

Samsung’s One UI 8.5 rollout began in Korea on May 6, bringing Galaxy AI upgrades to select flagship phones and tablets in phased markets. The wait is over. Samsung officially kicked off the stable ...

A few days ago, Samsung released the One UI 8.5 Beta 2 update for the Galaxy S23 series, Galaxy Z Flip5, Galaxy A36, and Galaxy A35. Now, the brand has expanded the rollout of the second One UI 8.5 ...

Java is an object-oriented programming language. To create objects and meaningfully initialize them, a developer must use a Java constructor. Constructors are a critical part of software development ...

As heap utilization approaches 100% and the inevitable OutOfMemoryError threatens to crash the production JVM, DevOps professionals who tend real-time Java ...

Get started with Java streams, including how to create streams from Java collections, the mechanics of a stream pipeline, examples of functional programming with Java streams, and more. You can think ...

In the years after the 2020 COVID-19 pandemic, it is clear that mRNA as a modality for vaccines and therapeutics is here to stay based on the number of mRNA programs currently in clinical development.